This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ablynx N.v., Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen. Active years: 2020-2025.
Company Filing History:
1 out of 174 
1 out of 1 Years Active: 2020-2025
Title: Veerle Compernolle: Innovator in Platelet Releasate and Nanobody Research
Introduction
Veerle Compernolle is a notable inventor based in Veldegem, Belgium. She has made significant contributions to the fields of biochemistry and medical research, particularly in the development of methods for preparing platelet releasate and nanobodies targeting the Interleukin-6 Receptor (IL-6R). With a total of 2 patents, her work has implications for both therapeutic and diagnostic applications.
Latest Patents
Compernolle's latest patents include innovative methods for preparing platelet releasate. This invention involves the use of specific quantities of water-soluble calcium salts and glass particles to extract platelet releasate from platelet-rich blood samples. The precise measurements of glass particles and calcium salts are crucial for the effectiveness of this method. Additionally, she has developed a nanobody against IL-6R, which comprises amino acid sequences capable of binding to multiple antigenic determinants of the receptor. This invention holds promise for various medical applications, including therapeutic and diagnostic uses.
Career Highlights
Throughout her career, Veerle Compernolle has worked with prominent organizations such as Ablynx N.V. and the Research and Development Fund of the Red Cross Flanders. Her experience in these companies has allowed her to advance her research and contribute to significant innovations in her field.
Collaborations
Compernolle has collaborated with esteemed colleagues, including Francis Descamps and Hendrik B. Feys. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Veerle Compernolle's contributions to the fields of platelet releasate and nanobody research exemplify her innovative spirit and dedication to advancing medical science. Her patents reflect her commitment to developing solutions that can improve therapeutic and diagnostic practices.